宝莱特股价小幅回落 中报业绩实现扭亏为盈

Core Viewpoint - Baolait's stock price closed at 9.99 yuan on August 18, 2025, down 1.48% from the previous trading day, with a trading volume of 330,852 hands and a transaction amount of 330 million yuan [1]. Group 1: Company Performance - Baolait operates in the medical device industry, focusing on the research, production, and sales of medical monitoring equipment and blood dialysis devices, widely used in hospitals and clinics [1]. - For the first half of 2025, Baolait reported total operating revenue of 523 million yuan and a net profit attributable to shareholders of 1.31 million yuan, marking a turnaround from a loss in the same period last year [1]. - The company's asset-liability ratio stands at 46.18%, showing a decrease compared to the same period last year [1]. - The net cash flow from operating activities was -24.75 million yuan, indicating an improvement from the previous year [1]. Group 2: Market Activity - On August 18, 2025, the net outflow of main funds was 27.36 million yuan, with a cumulative net outflow of 41.93 million yuan over the past five days [1].